Last deal

$12.5M

Amount

Venture - Series Unknown

Stage

06.08.2024

Date

1

all rounds

$12.5M

Total amount

General

About Company
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Also Known As

Ambrosia

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Operator of a drug discovery company intended to offer small molecule-based therapies for obesity and other metabolic disorders. The company's platform offers non-invasive methods for weight management and metabolic health, enabling patients to manage their conditions effectively with fewer side effects compared to some traditional medications.
Contacts

Phone number

Social url